Brief: Somnomed Posts Q2 Fy23 Revenue Of A$21.4 Million

SomnoMed

30/01/2023 01:32

Jan 30 (Reuters) - Somnomed Ltd  SOM.AX :
    * Q2 FY23 REVENUE OF A$21.4 MILLION, UP 16.6% VERSUS
PREVIOUS
CORRESPONDING PERIOD
    * SEES FY23 REVENUE GROWTH GUIDANCE HAS BEEN REVISED TO
BETWEEN
15-20%
    * SEES FY23 EBITDA GUIDANCE OF A$2M+, REMAINS UNCHANGED

Source text for Eikon:  ID:nASX64BZgB 
Further company coverage:  SOM.AX 
 ((Reuters.Briefs@thomsonreuters.com;))